Women's Health News

RSS

Additional therapy and screening may be needed for patients with mucinous breast cancer

In a large review of breast cancer patients with mucinous carcinoma, researchers at The University of Texas M. D. Anderson Cancer Center have identified an association between this rare type of breast cancer long-associated with a favorable prognosis and multiple tumors undetected by mammography or ultrasound.

14 Dec 2009

UCB offers tips for managing rheumatoid arthritis during festive season

A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season - Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food, writing cards and wrapping presents most difficult to do - Nearly two thirds of women living with rheumatoid arthritis experience pain daily

14 Dec 2009

African American women with breast cancer receive no follow-up care after lumpectomy, shows study

A new study finds many breast cancer patients - particularly African American women - do not receive recommended radiation treatments after undergoing a lumpectomy.

14 Dec 2009

Pfizer announces results from studies evaluating neratinib

Pfizer Inc. today announced results from studies evaluating neratinib (HKI-272), an investigational, orally administered, pan-ErbB inhibitor, in patients with human epidermal growth factor receptor-2 (HER2, also known as ErbB2) positive breast cancer at the 2009 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2009

Black women with HR-positive breast cancer have worse disease-free and overall survival, shows data

Black women with hormone receptor (HR)-positive breast cancer had worse disease-free and overall survival, according to data presented at the CTRC-AACR Annual San Antonio Breast Cancer Symposium, held Dec. 9-13, 2009.

14 Dec 2009

Ipsen announces preliminary results of phase I trial in metastatic breast cancer with BN83495

Ipsen today announced the preliminary results of a phase I trial in metastatic breast cancer with BN83495, Ipsen’s lead and first-in-class orally available irreversible steroid sulfatase (STS) inhibitor.

14 Dec 2009

Combination of Herceptin and chemotherapy improves treatment for women with HER2+ breast cancer

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

14 Dec 2009

Genentech announces positive results from Phase II study of T-DM1

Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.

14 Dec 2009

Findings from three studies using bioTheranostics' breast cancer molecular test reported

bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to drive personalized treatment, reported today findings from three studies using the company's breast cancer molecular test.

14 Dec 2009

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Incyte Corporation announced today positive results from an ongoing Phase I/II clinical trial for its selective oral sheddase inhibitor, INCB7839, involving 46 patients with HER2 positive metastatic breast cancer.

14 Dec 2009

Study examines the association of BRCA1 gene, infertility and breast/ovarian cancer

In a study published online this week in the leading cancer journal, Journal of Clinical Oncology, Westchester Medical Center Physician Dr. Kutluk Oktay, MD, Director, Division of Reproductive Medicine & Infertility concluded that mutations in the BRCA1 gene (gene associated with early onset breast cancer) are associated with early diminishment of egg reserve.

14 Dec 2009

Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics

Celldex Therapeutics, Inc. today announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers.

13 Dec 2009

Positive interim results of ARRY-380 in Phase 1 trial announced

Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 (ErbB2) inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.

13 Dec 2009

Lapatinib plus trastuzumab extend lives of HER2-positive breast cancer patients

Lapatinib plus trastuzumab are significantly better than lapatinib alone in extending the lives of breast cancer patients whose tumors are HER2-positive, according to Kimberly Blackwell, M.D., associate professor of medicine at Duke University Medical Center.

12 Dec 2009

Results from clinical survey of Oncotype DX on patients with node-positive breast cancer announced

Genomic Health, Inc. today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast cancer.

12 Dec 2009

Kaiser Permanente: Women of Chinese and Korean heritage may develop diabetes during pregnancy

More than 10 percent of women of Chinese and Korean heritage may be at risk for developing diabetes during pregnancy, according to a Kaiser Permanente study of 16,000 women in Hawaii that appears in the December issue of the Ethnicity and Disease journal.

11 Dec 2009

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

Anti-estrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium, held here Dec. 9-13, 2009.

11 Dec 2009

African-American women in South Carolina more likely to have cervical cancer than white women

African-American women in South Carolina are 37 percent more likely to have cervical cancer than white women and have a death rate that is about 61 percent higher, according to a study by researchers at the University of South Carolina's Arnold School of Public Health.

11 Dec 2009

Proposed changes to breast cancer screening criticized

The Editor-in-Chief of Cancer Investigation and one of the country's most respected medical policy professors has written a new commentary which criticizes proposed changes to breast cancer screening.

11 Dec 2009

Store brand infant formulas nutritionally equivalent to name-brand products

On October 1, changes were made to the federal WIC program that provides nutritional support to low-income women, infants and children. The goal of the new food package is to encourage breastfeeding because mother's milk is best for babies. Mothers who breastfeed will no longer receive any infant formula under the new program. Mothers who choose to formula feed may receive up to 26% fewer infant formula vouchers than were afforded in previous years.

11 Dec 2009

Women's Health News

Additional therapy and screening may be needed for patients with mucinous breast cancer

UCB offers tips for managing rheumatoid arthritis during festive season

African American women with breast cancer receive no follow-up care after lumpectomy, shows study

Pfizer announces results from studies evaluating neratinib

Black women with HR-positive breast cancer have worse disease-free and overall survival, shows data

Ipsen announces preliminary results of phase I trial in metastatic breast cancer with BN83495

Combination of Herceptin and chemotherapy improves treatment for women with HER2+ breast cancer

Genentech announces positive results from Phase II study of T-DM1

Findings from three studies using bioTheranostics' breast cancer molecular test reported

Incyte announces positive results from ongoing Phase I/II clinical trial for INCB7839

Study examines the association of BRCA1 gene, infertility and breast/ovarian cancer

Positive Phase 2 study results of CDX-011 reported by Celldex Therapeutics

Positive interim results of ARRY-380 in Phase 1 trial announced

Lapatinib plus trastuzumab extend lives of HER2-positive breast cancer patients

Results from clinical survey of Oncotype DX on patients with node-positive breast cancer announced

Kaiser Permanente: Women of Chinese and Korean heritage may develop diabetes during pregnancy

Anti-estrogens may reduce the risk of death from lung cancer, according to study results

African-American women in South Carolina more likely to have cervical cancer than white women

Proposed changes to breast cancer screening criticized

Store brand infant formulas nutritionally equivalent to name-brand products

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News